ÐÇ¿Õ´«Ã½

    Search
    Skip to main content
    Advertisement

    Novo Nordisk

    1. Business
    2. Pharmaceuticals
    3. Novo Nordisk
    Benzinga22:52
    The Motley Fool02:02
    Genetic Engineering and Biotechnology News06:44
    TipRanks03:40
    Benzinga01:05
    The Telegraph, Calcutta19:16
    Yahoo! UK & Ireland19:45

    Latest News

    In the last 8 hours
    Zacks10:52
    Earlier today
    Longevity Technology03:35
    Yesterday
    Korea Biomedical Review12:01 17-Dec-25
    Business Wire (Press Release)00:32 17-Dec-25
    PR Newswire (Press Release)00:06 17-Dec-25
    In the last 7 days
    Benzinga22:52 16-Dec-25
    The Telegraph, Calcutta20:00 16-Dec-25
    Mint13:12 16-Dec-25
    JD Supra09:37 16-Dec-25
    Zacks03:41 16-Dec-25
    Zacks02:09 16-Dec-25
    The Business Standard22:05 15-Dec-25
    BBC17:48 15-Dec-25
    Genetic Engineering and Biotechnology News06:44 15-Dec-25
    TipRanks03:50 15-Dec-25
    TipRanks03:40 15-Dec-25
    TipRanks03:40 15-Dec-25
    TipRanks03:40 15-Dec-25
    The Motley Fool02:02 15-Dec-25
    Las Vegas Review-Journal16:08 14-Dec-25
    The Financial Express00:48 14-Dec-25
    The Telegraph, Calcutta19:16 13-Dec-25
    The Financial Express15:39 13-Dec-25
    The Financial Express07:54 13-Dec-25
    The Economic Times06:50 13-Dec-25
    Benzinga06:21 13-Dec-25
    The Times of India04:34 13-Dec-25
    Zacks03:49 13-Dec-25
    The Hindu03:18 13-Dec-25
    The Week (India)01:48 13-Dec-25
    The Business Standard01:45 13-Dec-25
    Novo Nordisk01:14 13-Dec-25
    Benzinga01:05 13-Dec-25
    The Hindu Business Line00:15 13-Dec-25
    Pharmaceutical Technology00:08 13-Dec-25
    BNN Bloomberg00:02 13-Dec-25
    EasternEye23:47 12-Dec-25
    Yahoo! US23:33 12-Dec-25
    Investing.com23:13 12-Dec-25
    Outlook Business22:38 12-Dec-25
    RTE22:11 12-Dec-25
    DNA India21:40 12-Dec-25
    The Week (India)21:33 12-Dec-25
    The Telegraph, Calcutta21:24 12-Dec-25
    The Business Standard21:20 12-Dec-25
    NDTV.com20:55 12-Dec-25
    Invezz20:32 12-Dec-25
    Mint18:26 12-Dec-25
    The Hindu Business Line18:26 12-Dec-25
    The Times of India17:53 12-Dec-25
    The Times of India17:02 12-Dec-25
    Power Corridor16:05 12-Dec-25
    The Motley Fool12:48 12-Dec-25
    Zacks10:48 12-Dec-25
    The United States Senate Committee on Finance (Press Release)08:39 12-Dec-25
    The Star, Kenya02:51 12-Dec-25
    Mint00:58 12-Dec-25
    Yahoo! UK & Ireland19:45 11-Dec-25
    Yahoo! US19:41 11-Dec-25
    Bangkok Post14:34 11-Dec-25
    The Motley Fool08:50 11-Dec-25
    The Motley Fool04:46 11-Dec-25
    Zacks03:22 11-Dec-25
    pharmaphorum01:02 11-Dec-25
    The Business Standard00:52 11-Dec-25
    In the last month
    Outlook Business23:27 10-Dec-25
    Mint18:27 10-Dec-25
    The Business Standard18:25 10-Dec-25
    The Economic Times17:47 10-Dec-25
    National Law Review08:30 10-Dec-25
    Invezz07:52 10-Dec-25
    The Business Standard02:43 10-Dec-25
    Novo Nordisk01:11 10-Dec-25
    PMLiVE00:18 10-Dec-25
    TipRanks23:34 9-Dec-25
    Mint17:53 9-Dec-25
    Law36010:38 9-Dec-25
    The Motley Fool07:50 9-Dec-25
    The Economic Times14:07 8-Dec-25
    Benzinga16:08 7-Dec-25
    The Motley Fool03:23 6-Dec-25
    The Business Standard22:59 5-Dec-25
    Zacks22:51 5-Dec-25
    The Hindu Business Line21:24 5-Dec-25
    Yahoo! US21:07 5-Dec-25
    Washington Examiner20:15 5-Dec-25
    The Hindu Business Line14:15 5-Dec-25
    Zacks02:39 5-Dec-25
    PR Newswire (Press Release)02:04 5-Dec-25
    Malay Mail00:00 5-Dec-25
    Investing.com23:13 4-Dec-25
    IAM22:39 4-Dec-25
    Bundeskartellamt20:36 4-Dec-25
    Analytics India Magazine20:29 4-Dec-25
    The Hindu Business Line19:52 4-Dec-25
    The Hindu Business Line16:08 4-Dec-25
    Bloomberg Law15:54 4-Dec-25
    The Times of India14:38 4-Dec-25
    The Telegraph, Calcutta13:01 4-Dec-25
    Yahoo! US05:11 4-Dec-25
    TipRanks02:59 4-Dec-25
    Zacks02:31 4-Dec-25
    The Motley Fool02:04 4-Dec-25
    Global News01:51 4-Dec-25
    PR Newswire (Press Release)00:31 4-Dec-25
    The Times of India22:10 3-Dec-25
    The Times of India20:49 3-Dec-25
    Outlook Business18:47 3-Dec-25
    The Times of India13:01 3-Dec-25
    ScienceNorway10:06 3-Dec-25
    The Economic Times06:43 3-Dec-25
    Medpage Today06:20 3-Dec-25
    Oprah Daily05:15 3-Dec-25
    Mint04:02 3-Dec-25
    BNN Bloomberg03:06 3-Dec-25
    view more headlines
    18 Dec 10:52

    About our Novo Nordisk news

    Latest news on Novo Nordisk, a global healthcare company focused on diabetes care, obesity treatment, and other serious chronic diseases. Get updates on Novo Nordisk's products, research, financial performance, and stock price.

    Novo Nordisk is a Danish multinational pharmaceutical company headquartered in Bagsværd, Denmark. Founded in 1923, the company has grown to become a global leader in diabetes care, with a strong presence in the fields of hemophilia, growth hormone therapy, and obesity treatment. Novo Nordisk's key products include insulin analogs like Tresiba and Levemir, GLP-1 receptor agonists such as Victoza and Ozempic, and obesity drugs like Saxenda and Wegovy.

    Stay informed about the latest developments in Novo Nordisk's research and development pipeline, including updates on clinical trials, regulatory approvals, and new product launches. Our feed covers the company's ongoing efforts to innovate and improve treatments for diabetes, obesity, and other metabolic disorders, such as the development of oral semaglutide and the exploration of novel drug targets.

    In addition to product news, our Novo Nordisk feed keeps you updated on the company's financial performance, including quarterly earnings reports, sales figures, and market share data. We also cover key events and announcements that may impact Novo Nordisk's stock price (NYSE: NVO), such as strategic partnerships, acquisitions, and leadership changes.

    Beyond the business aspects, our feed highlights Novo Nordisk's commitment to corporate social responsibility and sustainability. From initiatives to improve access to diabetes care in developing countries to efforts to reduce the company's environmental footprint, we provide a comprehensive view of Novo Nordisk's impact on global health and society.

    As the prevalence of diabetes and obesity continues to rise worldwide, Novo Nordisk plays a crucial role in addressing these global health challenges. Our ÐÇ¿Õ´«Ã½ feed on Novo Nordisk brings you the most relevant and up-to-date information from reliable sources, helping you stay informed about this innovative and influential healthcare company.

    Pharmaceuticals Top Stories

    STAT05:42
    NJ.com - The Star-Ledger04:03
    European Pharmaceutical Manufacturer21:13
    MassLive.com00:07
    European Pharmaceutical Review23:40

    Business Top Stories

    ShareCafe08:45ASX AI IT
    ABC Online07:54ASX AI IT
    Business News Australia15:33Treasury Wine Estates ASX
    ShareCafe12:21Treasury Wine Estates ASX
    Money Magazine09:30
    Proactive Investors (Australia)05:22
    CommBank18:18Australian Economy
    ShareCafe15:45Australian Economy
    Business News Australia16:45ASX
    Business News Australia12:29ASX
    Publication filters

    Headline Density

    Sorry, no headlines or news topics were found. Please try different keywords.